GAN & LEE PHARMACEUTICALS

Gan & Lee’s flat Shanghai market performance shows why investors fear a stagnant insulin maker – lack of R&D, thin liquidity and no new partners keep shares stuck below a 52‑week high.

Gan & Lee 603087.SS stock: flat price at CNY 69.67, 405.6 m volume, 42 b market cap, and 2.96% drop vs. month‑end – see full 200‑day, 52‑week context.